Cargando…

Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: A parallel, randomized, double blind study

BACKGROUND: Recombinant human erythropoietin (EPO) is used for the treatment of last stage renal anemia. A new EPO preparation was obtained in Cuba in order to make this treatment fully nationally available. The aim of this study was to compare the pharmacokinetic, pharmacodynamic and safety propert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Oliva, Jorge F, Casanova-González, Martha, García-García, Idrian, Porrero-Martín, Pedro J, Valenzuela-Silva, Carmen M, Hernández-Montero, Tairí, Lagarde-Ampudia, Marcia, Casanova-Kutsareva, Yuri, Ávila-Albuerne, Yisel, Vargas-Batista, Alicia, Bobillo-López, Hailen, Herrera-Valdés, Raúl, López-Saura, Pedro A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164417/ https://www.ncbi.nlm.nih.gov/pubmed/15910687 http://dx.doi.org/10.1186/1471-2369-6-5

Ejemplares similares

Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study
por: Suárez-Méndez, Roberto, et al.
Publicado: (2004)

Erythropoietin-producing tubercle granuloma in a hemodialysis patient
por: Satoh, Minoru, et al.
Publicado: (2013)

Obesity may be erythropoietin dose-saving in hemodialysis patients
por: El-Kannishy, Ghada M., et al.
Publicado: (2018)

Erythropoietin treatment and the risk of hip fractures in hemodialysis patients
por: Suresh, Sukanya, et al.
Publicado: (2021)

Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study
por: Milanés-Virelles, María T, et al.
Publicado: (2008)

Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes
por: Schneider, Andreas, et al.
Publicado: (2013)

Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients
por: Takata, Tomoaki, et al.
Publicado: (2021)

Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress
por: Joksimovic Jovic, Jovana, et al.
Publicado: (2022)

Predictors of iron versus erythropoietin responsiveness in anemic hemodialysis patients
por: Hildebrand, Sarah, et al.
Publicado: (2022)

Influence of Tunneled Hemodialysis-Catheters on Inflammation and Mortality in Dialyzed Patients
por: Crespo-Montero, Rodolfo, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers
por: García-García, Idrian, et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study
por: García-García, Idrian, et al.
Publicado: (2010)

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2015)

Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients
por: Coronado Daza, J. A., et al.
Publicado: (2019)

Comparing the effects of intravenous and subcutaneous Erythropoietin on blood indices in hemodialysis patients
por: Ghasemi, Faramarz, et al.
Publicado: (2019)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
por: Zhu, Yifan, et al.
Publicado: (2022)

How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients
por: Dimitrijevic, Zorica M., et al.
Publicado: (2012)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients
por: Agarwal, Gaurav, et al.
Publicado: (2016)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
por: Rahbar, Maryam, et al.
Publicado: (2017)

Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2016)

Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality
por: Streja, Elani, et al.
Publicado: (2016)

Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
por: Hung, Peir-Haur, et al.
Publicado: (2019)

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
por: Munie, Stephanie, et al.
Publicado: (2021)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021)

The Relationship Between Erythropoietin Resistance and Antibody Response to Hepatitis B Vaccine in Hemodialysis Patients
por: Afsar, Baris
Publicado: (2013)

Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis
por: Oh, Jieun, et al.
Publicado: (2014)

Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin
por: González-Ortiz, Ailema, et al.
Publicado: (2019)

ACE gene polymorphism and its association with serum erythropoietin and hemoglobin ‎in Iraqi hemodialysis patients
por: Al-Radeef, Mohanad Yasir, et al.
Publicado: (2019)

Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
por: Yu, Wei-Hong, et al.
Publicado: (2020)

Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
por: Hung, Peir‐Haur, et al.
Publicado: (2021)

Effects of Low-Flux and High-Flux Dialysis Membranes on Erythropoietin Responsiveness in Hemodialysis Patients
por: Abdelhamid, Walid A. R., et al.
Publicado: (2022)

TNF-α and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica
por: Pentón-Rol, Giselle, et al.
Publicado: (2009)

Gas Sensing Properties of Perovskite Decorated Graphene at Room Temperature
por: Casanova-Cháfer, Juan, et al.
Publicado: (2019)

Unraveling the Gas-Sensing Mechanisms of Lead-Free Perovskites Supported on Graphene
por: Casanova-Chafer, Juan, et al.
Publicado: (2022)

Flanker Task-Elicited Event-Related Potential Sources Reflect Human Recombinant Erythropoietin Differential Effects on Parkinson's Patients
por: Bringas Vega, Maria L., et al.
Publicado: (2020)

In Reply to "The Relationship Between Erythropoietin Resistance and Antibody Response to Hepatitis B Vaccine in Hemodialysis Patients"
por: Beladimusavi, Seyfollah, et al.
Publicado: (2013)

Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin
por: Rafiean-Kopaie, Mahmoud, et al.
Publicado: (2013)

Circulating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients
por: Chen, Miao-Pei, et al.
Publicado: (2016)

Negative Relationship between Erythropoietin Dose and Blood Lead Level in Patients Undergoing Maintenance Hemodialysis
por: Huang, Wen-Hung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_42gnjjvsf0f68qu01eolpfbgie